Inhibrx Biosciences, Inc. ($INBX)
Filing Information
| Accession Number | 0001366074-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 8, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
25,000
Total Value
$2,645,399.31
P&L
-1.0% ($27,149.31)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 8, 2026 | Purchase | 5,895 | $99.29 | $585,342.85 | 711,443 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Purchase | 6,605 | $100.64 | $664,719.27 | 718,048 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Purchase | 1,100 | $107.12 | $117,836.29 | 719,148 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Purchase | 500 | $108.23 | $54,117.50 | 719,648 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Purchase | 1,219 | $111.88 | $136,382.33 | 720,867 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Purchase | 9,681 | $112.28 | $1,087,001.07 | 730,548 | Indirect | By the Lappe Family Trust | View Details |